These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2496149)

  • 1. Chronic treatment with fluvoxamine, clovoxamine, and placebo: interaction with digoxin and effects on sleep and alertness.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B; Labedski L
    J Clin Pharmacol; 1989 Jan; 29(1):91-5. PubMed ID: 2496149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man.
    Saletu B; Grünberger J; Rajna P; Karobath M
    J Neural Transm; 1980; 49(1-2):63-86. PubMed ID: 6777458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo controlled study of the cardiovascular effects of fluvoxamine and clovoxamine in human volunteers.
    Robinson JF; Doogan DP
    Br J Clin Pharmacol; 1982 Dec; 14(6):805-8. PubMed ID: 6817771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients.
    Norton KR; Sireling LI; Bhat AV; Rao B; Paykel ES
    J Affect Disord; 1984 Dec; 7(3-4):297-308. PubMed ID: 6241211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-independent pharmacokinetics of digoxin in humans.
    Ochs HR; Greenblatt DJ; Bodem G; Harmatz JS
    Am Heart J; 1978 Oct; 96(4):507-11. PubMed ID: 358815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteers.
    Wilson SJ; Bailey JE; Alford C; Nutt DJ
    J Psychopharmacol; 2000; 14(4):378-86. PubMed ID: 11198056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression.
    Itil TM; Shrivastava RK; Mukherjee S; Coleman BS; Michael ST
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):433S-438S. PubMed ID: 6407504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of clovoxamine on the sleep of depressed patients. "Polygraphic recordings"].
    Minot R; Crocq MA; Roussel B; Marie-Cardine M
    Encephale; 1985; 11(2):65-70. PubMed ID: 4017939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute comparison of clovoxamine and mianserin, alone and in combination with ethanol, on human psychomotor performance.
    Strömberg C; Mattila MJ
    Pharmacol Toxicol; 1987 May; 60(5):374-9. PubMed ID: 3615347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial clinical evaluation of a new nontricyclic antidepressant: clovoxamine.
    Freeman HL; Wakelin JS; Calanca A; Hole G
    Adv Biochem Psychopharmacol; 1982; 32():69-75. PubMed ID: 7046368
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients.
    Gelenberg AJ; Wojcik JD; Newell C; Lamping DL; Spring B
    J Clin Psychopharmacol; 1985 Feb; 5(1):30-4. PubMed ID: 3882774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects.
    Curran HV; Lader M
    Eur J Clin Pharmacol; 1986; 29(5):601-7. PubMed ID: 3082644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing.
    De Wilde JE; Mertens C; Wakelin JS
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):427S-431S. PubMed ID: 6407503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of repeated doses of fluvoxamine, mianserin and placebo on memory and measures of sedation.
    Curran HV; Shine P; Lader M
    Psychopharmacology (Berl); 1986; 89(3):360-3. PubMed ID: 3088664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clovoxamine kinetics in an early clinical trial.
    Hurst HE; Jones DR; Wright JH; Jarboe CH
    Clin Pharmacol Ther; 1983 Aug; 34(2):266-71. PubMed ID: 6872422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of clovoxamine concentration in human plasma by electron capture gas chromatography.
    Hurst HE; Jones DR; Jarboe CH; deBree H
    Clin Chem; 1981 Jul; 27(7):1210-2. PubMed ID: 7237785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine.
    Dick P; Ferrero E
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):419S-425S. PubMed ID: 6407502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of a pre-column for the direct high-performance liquid chromatographic determination of the anti-depressants clovoxamine and fluvoxamine in plasma.
    de Jong GJ
    J Chromatogr; 1980 Aug; 183(2):203-11. PubMed ID: 6772658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics.
    Culm-Merdek KE; von Moltke LL; Harmatz JS; Greenblatt DJ
    Br J Clin Pharmacol; 2005 Nov; 60(5):486-93. PubMed ID: 16236038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.